Eric J. Feldman

9.3k citations
195 papers · 6.7k · 1 hit paper · h-index 42

Impact in

  • Hematology top 0.1%
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
    • Multiple Myeloma Research and Treatments
    • Hematopoietic Stem Cell Transplantation
  • Genetics top 0.5%
    • Chronic Lymphocytic Leukemia Research
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

    • Acute Myeloid Leukemia Research 102
    • Chronic Myeloid Leukemia Treatments 36
    • Histone Deacetylase Inhibitors Research 19
    • Retinoids in leukemia and cellular processes 18
    • Protein Degradation and Inhibitors 16

Eric J. Feldman

187 papers receiving 6.6k citations

Eric J. Feldman's Hit Papers

Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion 2006 · 900 citations
9000+6+13Years since publication250500750

Peers

Eric J. Feldman
Comparison fields: 5 of 114
  • Hematology 4.0k
  • Genetics 1.6k
  • Oncology 1.2k
  • Molecular Biology 2.6k
  • Pathology and Forensic Medicine 534
Replace Jeffrey E. Lancet with:
Jeffrey E. Lancet United States
Gail J. Roboz United States
Christian Récher France
David A. Rizzieri United States
B. Douglas Smith United States
Adriano Venditti Italy
William Blum United States
Gerrit Jan Schuurhuis Netherlands
Marilyn L. Slovak United States
Jeffrey Tyner United States
Eric J. Feldman relative to Jeffrey E. Lancet United States Jeffrey E. Lancet's profile →
Citations per field
00.5×1.5×
Jeffrey E. Lancet · 1×
Citations per year

Countries citing papers authored by Eric J. Feldman

Since Specialization
Citations

This map shows the geographic impact of Eric J. Feldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric J. Feldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric J. Feldman more than expected).

Fields of papers citing papers by Eric J. Feldman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric J. Feldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric J. Feldman. The network helps show where Eric J. Feldman may publish in the future.

Co-authors

The 25 scholars most cited alongside Eric J. Feldman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eric J. Feldman Line = papers co-authored together Eric J. Feldman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 195 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion
Hit paper breakdown →
2006900
2 2010413
3 2007311
4 2014265
5 2011241
6 2005211
7 2005193
8 2008186
9 2004184
10 1996157
11
Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.
1990145
12 2014131
13 2006129
14 2012102
15 200798
16 201294
17 201189
18 199289
19 201187
20 201286

About Eric J. Feldman

Eric J. Feldman is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Public Health, Environmental and Occupational Health, having authored 195 papers that have together received 6.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (102 papers), Chronic Myeloid Leukemia Treatments (36 papers), Acute Lymphoblastic Leukemia research (29 papers), Chronic Lymphocytic Leukemia Research (25 papers), Histone Deacetylase Inhibitors Research (19 papers), Retinoids in leukemia and cellular processes (18 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers) and Protein Degradation and Inhibitors (16 papers). The work is most often cited by research in Hematology (4.0k citations), Genetics (1.6k citations), Oncology (1.2k citations), Molecular Biology (2.6k citations) and Pathology and Forensic Medicine (534 citations). Eric J. Feldman has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Richard M. Stone, Gail J. Roboz, Alan F. List, Karen Seiter, Peter L. Greenberg, Tauseef Ahmed, Azra Raza, John M. Bennett, Jeffrey E. Lancet and Kenton Wride. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia Research, Acta Haematologica and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact